Medicare Enrolled
Dr. Thomas Rechtschaffen, M.D.
Urology Physician · Yonkers, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rechtschaffen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rechtschaffen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rechtschaffen
Dr. Thomas Rechtschaffen is an urology physician in Yonkers, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rechtschaffen performed 3,538 Medicare services across 1,885 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rechtschaffen received a total of $59,159 from 67 pharmaceutical and/or device companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rechtschaffen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in NY
$59,159 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,538
Medicare services
Top 24% in NY for urology physician
1,885
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 714 | $68 | $287 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
502 | $107 | $441 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
428 | $1 | $2 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
307 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
158 | $83 | $313 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
119 | $8 | $9 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
114 | $58 | $231 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
112 | $8 | $24 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
110 | $133 | $495 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
108 | $8 | $26 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
107 | $231 | $942 |
| PSA test (prostate cancer screening) | 104 | $18 | $55 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $138 | $579 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
64 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
64 | $8 | $24 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
62 | $33 | $121 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
50 | $25 | $77 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $13 | $49 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
36 | $57 | $220 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
33 | $216 | $951 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
33 | $35 | $90 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
21 | $10 | $43 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
18 | $22 | $273 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
18 | $18 | $55 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $168 | $1,305 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $18 | $227 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
17 | $83 | $691 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
15 | $5 | $191 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $122 | $446 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $141 | $1,443 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
14 | $5 | $14 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
12 | $8 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.6% high complexity
22.3% medium
74.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$59,159
Total received (2018-2024)
Avg $8,451/year across 7 years
Top 5% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
806
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$36,006 (60.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,583 (28.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,569 (11.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$12,771
2023
$7,000
2022
$6,937
2021
$7,007
2020
$7,287
2019
$5,436
2018
$12,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$9,611
UROGEN PHARMA, INC.
$1,222
Sumitomo Pharma America, Inc.
$388
PFIZER INC.
$237
Teleflex LLC
$176
Antares Pharma, Inc.
$131
Myriad Genetic Laboratories, Inc.
$127
Astellas Pharma US Inc
$116
Medtronic, Inc.
$111
Tolmar, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$84
Endo USA, Inc.
$64
Edap Technomed Inc
$60
LANTHEUS MEDICAL IMAGING, INC.
$51
COLOPLAST CORP
$42
Merck Sharp & Dohme LLC
$39
ACCORD HEALTHCARE, INC.
$36
Blue Earth Diagnostics Limited
$30
DENTSPLY IH AB
$29
Dendreon Pharmaceuticals LLC
$28
Endo Pharmaceuticals Inc.
$24
Axonics, Inc.
$23
Laborie Medical Technologies Corp.
$23
Cook Medical LLC
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Top 3 companies account for 87.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$26,788
Bayer HealthCare Pharmaceuticals Inc.
$7,054
Johnson & Johnson Health Care Systems Inc.
$3,750
PFIZER INC.
$3,357
AbbVie, Inc.
$2,155
Astellas Pharma US Inc
$2,122
UROGEN PHARMA, INC.
$1,344
Endo Pharmaceuticals Inc.
$1,209
Dendreon Pharmaceuticals LLC
$1,056
PROCEPT BioRobotics Corporation
$846
Sumitomo Pharma America, Inc.
$763
Antares Pharma, Inc.
$593
Coloplast Corp
$496
UROVANT SCIENCES INC
$475
Medtronic USA, Inc.
$467
NeoTract Inc.
$457
Axonics, Inc.
$441
Janssen Scientific Affairs, LLC
$422
Teleflex LLC
$418
Allergan Inc.
$390
Medtronic, Inc.
$383
Acerus Pharmaceuticals Corporation
$351
EDAP TECHNOMED INC
$300
Bayer Healthcare Pharmaceuticals Inc.
$300
Myovant Sciences Inc.
$275
ABBVIE INC.
$256
Progenics Pharmaceuticals, Inc.
$223
Aytu BioScience, Inc
$182
Myriad Genetic Laboratories, Inc.
$172
Merck Sharp & Dohme LLC
$166
TOLMAR Pharmaceuticals, Inc.
$115
Clarus Therapeutics Inc.
$107
Blue Earth Diagnostics Limited
$101
Janssen Products, LP
$100
Cook Incorporated
$98
Merck Sharp & Dohme Corporation
$96
Boston Scientific Corporation
$88
COLOPLAST CORP
$88
Tolmar, Inc.
$85
Amgen Inc.
$77
ACCORD HEALTHCARE, INC.
$70
UroGen Pharma, Inc.
$69
Ferring Pharmaceuticals Inc.
$64
Endo USA, Inc.
$64
Allergan, Inc.
$62
Edap Technomed Inc
$60
KOELIS Inc.
$58
Avadel Specialty Pharmaceuticals, LLC
$52
LANTHEUS MEDICAL IMAGING, INC.
$51
Laborie Medical Technologies Corp.
$40
Aytu Bioscience, Inc
$40
180 Medical, Inc.
$39
Supernus Pharmaceuticals, Inc.
$37
BOSTON SCIENTIFIC CORPORATION
$34
Cook Medical LLC
$30
DENTSPLY IH AB
$29
Telix Pharmaceuticals
$27
Alnylam Pharmaceuticals Inc.
$23
Photocure Inc
$21
Olympus America Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
AbbVie Inc.
$18
Alfasigma USA, Inc.
$17
DENTSPLY IH Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
C. R. BARD, INC. & SUBSIDIARIES
$13
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 63.5% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · Axumin · BOTOX · BOTOX - UROLOGY · Bulkamid · CAMCEVI · COOK · COOK MEDICAL STENTS · COOK MEDICAL UROLOGY · CYSVIEW · ClosureRFS · ELIGARD · ERLEADA · Erleada · FEMALE INCONTINENCE · FIRMAGON · GEMTESA · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · General - Erectile Dysfunction · General - Kidney Stone Disease · GentleCath · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHO 150 · LOFRIC · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PELVIC FLOOR REPAIR · POSLUMA · PRECISETUMOR · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · RESTORELLE · SPEEDICATH · SUSPEND · Saffron · TOVIAZ · Trinity · UROLIFT · UroLift · VERIFY · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (61%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for urology physician in NY.
Geographic Context
Urology physicians within 10 mi
718
Per 100K population
72.0
County median income
$118,411
Nearest hospital
ST JOSEPH'S MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rechtschaffen is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with consulting-driven industry engagement in the top 5% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rechtschaffen experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Rechtschaffen performed 714 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rechtschaffen receive payments from pharmaceutical companies?
Yes. Dr. Rechtschaffen received a total of $59,159 from 67 companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rechtschaffen's costs compare to other urology physicians in Yonkers?
Dr. Rechtschaffen's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rechtschaffen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Yonkers
Browse urology physicians in Yonkers ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Johnson & Johnson Health Care Systems Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Health Care Systems Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology